Purchase Order N0017324P5432

Award Date 9/6/24
Potential Completion Date 9/9/24
Potential Value $9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Washington, DC 20375, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of the Navy Office of Naval Research awarded a $14,500 firm-fixed-price purchase order contract to Biolytic Lab Performance Inc., a for-profit veteran-owned business. The contract is for the provision of full service plan products and services, including oligo synthesizers, chemistry instruments, laboratory equipment, maintenance agreements, warranty renewals, and other scientific products and services. The contract does not have a set-aside designation. Biolytic Lab Performance...
This federal contract award is for $9,500 and was issued by the Office of Naval Research, a defense agency, to Biolytic Lab Performance Inc., a veteran-owned for-profit organization. The contract is a firm-fixed-price purchase order that does not have a set-aside designation. The contract provides for the procurement of parts, labor, travel, and expenses related to the maintenance of PM (presumably "preventative maintenance") services. Biolytic Lab Performance Inc. specializes in DNA...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Biolytic Lab Performance Inc., a veteran-owned, for-profit organization that specializes in DNA synthesis solutions. The contract, valued at $56,000.00, is for the maintenance of Biolytic's DR. OLIGO 48 DNA synthesizers. The contract has a completion date of February 9, 2026. Biolytic Lab Performance Inc. has extensive experience providing DNA synthesizers, related instruments,...
The U.S. Department of Defense's Uniformed Services University of the Health Sciences awarded a $114,170.00 firm-fixed-price purchase order contract for one DR.OLIGO 48 AUTO CHEMISTRY INSTRUMENT to Biolytic Lab Performance Inc. The contract is a 100% small business set-aside and was awarded on September 26, 2022, with a completion date of March 15, 2023. Biolytic Lab Performance Inc. is a veteran-owned for-profit organization that provides DNA synthesis solutions, including oligonucleotide...
This firm fixed-price purchase order was awarded to Biolytic Lab Performance Inc., a veteran-owned for-profit organization, by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia. The $54,000 contract is for the maintenance of a medium throughput DNA synthesizer and 42 related reagents. The award was not set aside for any specific business category. Biolytic Lab Performance Inc. specializes in providing scientific instrumentation, particularly oligonucleotide synthesizers...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a firm fixed-price purchase order contract to Biolytic Lab Performance Inc., a veteran-owned for-profit organization, for the procurement of a DR. OLIGO Synthesizer. The contract, valued at $84,950.00, has an ultimate completion date of April 30, 2020. Biolytic Lab Performance Inc. is a federal contractor that specializes in DNA synthesis solutions and laboratory equipment, and has secured multiple awards from various civilian and...
The Department of the Navy, Secretary of the Navy Office of Naval Research awarded a $51,390 firm fixed price purchase order to Kilobaser Corporation for a benchtop DNA and RNA synthesizer. The award stemmed from a March 2024 special notice posted on the Federal Business Opportunities website announcing the Navy's intent to award a sole source contract to Kilobaser to fulfill its requirements. No set-aside was used for this procurement. Performance will take place in Washington, D.C. and must be...
The U.S. Navy's Office of Naval Research (ONR) awarded a firm-fixed-price purchase order contract to Biolog, Inc., a for-profit manufacturer of specialized microbiological testing supplies and instruments, for the delivery of ODIN INSTRUMENT. The $154,623.87 contract, which has an ultimate completion date of April 12, 2024, does not utilize any set-aside designations. Biolog, headquartered in St. Louis, Missouri, is an established federal contractor providing products and services to various...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Biolytic Lab Performance Inc., a veteran-owned for-profit organization. The contract, valued at $84,950.00, is for the provision of an OLIGO INST (oligonucleotide instrument), with a performance period ending on July 20, 2021. The contract has no set-aside designation. Biolytic Lab Performance Inc. is a provider of DNA synthesis solutions and laboratory equipment, having secured...
The Department of the Navy, Office of Naval Research awarded a $71,520 purchase order to Pressure Biosciences, Inc. of Washington, D.C. for BAROCYCLER equipment. The firm fixed price contract runs from September 25, 2023 through October 2, 2023 and will provide BAROCYCLER devices to support the Office of Naval Research's research and development activities. No set aside designation or subcontractors were identified. The Office of Naval Research oversees the Navy's science and technology...

The U.S. Office of Naval Research (ONR) awarded a $8,995.00 firm fixed-price purchase order to Biolytic Lab Performance Inc., a veteran-owned for-profit organization, for the repair of equipment. The contract has a completion date of September 9, 2024 and was not set aside for any specific business type. Biolytic Lab Performance Inc. is a provider of DNA synthesis solutions, including oligonucleotide synthesizers, chemistry instruments, and laboratory equipment, to various federal agencies such as the Department of Health and Human Services Centers for Disease Control and Prevention, the Department of the Navy, and the Uniformed Services University of the Health Sciences. The company has also received a research grant from the National Institutes of Health National Institute of General Medical Sciences for developing a technology related to single-cell DNA synthesis applications.

Generated 12/6/24, 9:02 AM